{"entity":{"id":"advance-care-planning-for-adults-with-cancer","kind":"protocol","name":"Advance care planning for adults with cancer: the conversation, the record, sharing and review","aka":["advance care planning","ACP","planning ahead","future care planning","anticipatory care planning","advance statement","what matters to me conversation","planning for future care"],"tldr":"Advance care planning is a series of conversations, always your choice, in which you tell your care team and those close to you what matters to you and what care you would want if you later could not speak for yourself. Your team should offer it, write down what is said and agree the notes with you, give you a copy, share it with your consent, and look at it again when your treatment is reviewed.","summary":"This page describes how advance care planning is meant to be done so that patients and families know what to expect and what to ask for; your own team's process and local forms come first. NICE NG108, which is to be read with the Mental Capacity Act 2005 (the law in England and Wales), asks every practitioner who meets a person after diagnosis to help them make an informed choice about taking part, to offer the discussion at the most suitable time after diagnosis and again later, to be ready to postpone it, to take account of the person's history, wishes, feelings, values and beliefs, to help them anticipate how their needs may change, to keep contemporaneous notes agreed with the person, to give them an accessible record, to share it with consent and to review it at reviews of treatment. NICE NG142 and quality standard QS13 place the offer with adults approaching the end of life, identified systematically, and ask that a copy of the plan is where the person lives and goes with them into hospital, a care home or a hospice. NG108 distinguishes the forms planning can take: advance decisions to refuse treatment and the appointment of an attorney are legally binding, while advance statements are not but must be considered carefully. In England and Wales the Mental Capacity Act 2005 requires anyone deciding a person's best interests to consider any relevant written statement the person made while they had capacity. The trial evidence is weaker than the guidance: in the ACTION cluster-randomised trial (1,117 patients with advanced lung or colorectal cancer, six European countries) structured conversations with trained facilitators did not change quality of life at 12 weeks; 67 per cent of patients found the conversations helpful and 16 per cent found them distressing; a 2025 meta-analysis of 14 randomised studies found more advance directives completed and more use of palliative care, with no difference in anxiety, depression, satisfaction or quality of life. NHS England's Universal Principles for Advance Care Planning (2022) and the GMC's guidance on care towards the end of life could not be read, because both sites refused a script.","asOf":"2026-11-17","links":[],"tags":[],"related":["respect-and-dnacpr-decisions","early-palliative-care-referral","care-in-the-last-days-of-life","palliative-sedation-for-refractory-suffering","strong-opioids-for-cancer-pain","distress-screening-and-referral","consent-and-education-before-anticancer-treatment","palliative-care","hospice-end-of-life"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["advance-care-planning","advance-decision-to-refuse-treatment","lasting-power-of-attorney-health-welfare","respect-process","serious-illness-conversation-guide","gold-standards-framework","prognostic-evaluation-advanced-cancer"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"simple":"This is a conversation about your future care, and you decide whether and when to have it. You say what matters to you and who should be involved. It is written down, you keep a copy, and you can change it for as long as you are able to make these decisions.","domain":"palliative","setting":{"who":["doctor","nurse","multidisciplinary-team","patient-or-carer"],"where":["outpatient-clinic","ward","home","community"]},"population":"Adults with cancer who have the mental capacity to discuss their future care: NICE NG108 says planning should be offered to everyone at risk of losing capacity, for example through progressive illness, and NICE NG142 covers adults approaching the end of life. The steps are from NICE guidelines, which are to be read with the Mental Capacity Act 2005, and from the Act itself, which extends to England and Wales only; the law in Scotland and Northern Ireland was not read. None of the step sources is specific to cancer. Children and young people are outside this record, as are the ReSPECT form and resuscitation decisions, which have their own. Taking part is voluntary at every step, and your own team's process and local documents come first.","trigger":"A diagnosis that makes planning ahead useful, the person being thought to be approaching the end of life, a review of treatment or support, or the person asking.","steps":[{"action":"Have a system that identifies adults who are likely to be approaching the end of life, so that the offer of planning is not left to chance","why":"NICE's committee agreed that identifying these adults supports practitioners to start discussions about advance care planning, although it called the evidence limited.","source":"nice-ng142","quote":"People managing and delivering services should develop systems to identify adults who are likely to be approaching the end of their life (for example, using tools such as the Gold Standards Framework, the Amber Care Bundle or the Supportive and Palliative Care Indicators Tool [SPICT]).","grade":"Not graded (NICE NG142 1.1.1)"},{"action":"Help the person make an informed choice about whether to take part, whichever professional they are seeing","why":"Planning ahead is optional, and a person can only choose it if someone has explained that it exists and what it involves.","source":"nice-ng108","quote":"All health and social care practitioners who come into contact with the person after diagnosis should help them to make an informed choice about participating in advance care planning.","grade":"Not graded (NICE NG108 1.1.33)"},{"action":"Offer the discussion at a suitable time after the diagnosis, and offer it again later","why":"NICE asks for more than one offer so that people can think through different issues in their own time.","source":"nice-ng108","quote":"Offer the person a discussion about advance care planning: at the most suitable time once they receive a diagnosis likely to make advance care planning useful and at other times, allowing people to think through and address different issues in their own time.","grade":"Not graded (NICE NG108 1.1.34)"},{"action":"Offer accessible spoken and written information about advance care planning, including how it relates to the person's own circumstances and condition","why":"A person can only make an informed choice about planning if they have been told what it is and how it applies to them.","source":"nice-ng108","quote":"Offer people accessible verbal and written information about advance care planning, including how it relates to their own circumstances and conditions.","grade":"Not graded (NICE NG108 1.1.31)"},{"action":"Be sensitive to people who prefer not to talk about this or not to have a plan, and be ready to postpone the discussion if the person wishes","why":"Some people are not ready, or prefer not to plan in this way, and nobody should feel pushed into the conversation.","source":"nice-ng108","quote":"be prepared to postpone discussions until a later date, if the person wishes","grade":"Not graded (NICE NG108 1.1.36)"},{"action":"During the discussion, take account of the person's history, circumstances, wishes and feelings, values and beliefs, and anything else they consider important","why":"NICE describes planning ahead as a way for people to exercise their personal autonomy as far as possible, so the discussion starts from what matters to the person.","source":"nice-ng108","quote":"take into account the person's history, social circumstances, wishes and feelings, values and beliefs (including religious, cultural and ethnic factors), aspirations and any other factors they may consider important to them","grade":"Not graded (NICE NG108 1.1.39)"},{"action":"Help the person think ahead about how their needs may change in the future","why":"A plan is about care the person does not need yet, so NICE asks practitioners to help them anticipate it.","source":"nice-ng108","quote":"help the person to anticipate how their needs may change in the future.","grade":"Not graded (NICE NG108 1.1.39)"},{"action":"Make sure you have access to the information about the person's medical condition that you need to support the planning","why":"NICE makes it the practitioner's responsibility to identify what information they need.","source":"nice-ng108","quote":"Practitioners involved in advance care planning should ensure that they have access to information about the person's medical condition that helps them to support the advance care planning process.","grade":"Not graded (NICE NG108 1.1.35)"},{"action":"Take reasonable steps to include family, friends, carers or an advocate if the person has consented, and provide communication support such as an interpreter where it is needed","why":"If the person later cannot decide for themselves, the Mental Capacity Act asks whoever decides to take account of the views of those caring for them, where it is practicable and appropriate to consult them.","source":"nice-ng108","quote":"If the person has given consent for carers, family and friends or advocates to be involved in discussions about advance care planning, practitioners should take reasonable steps to include them.","grade":"Not graded (NICE NG108 1.1.37)"},{"action":"Give information on the process of planning, including that some forms are legally binding (an advance decision to refuse treatment, appointing an attorney) and others are not (an advance statement)","why":"NICE says an advance statement has no legal force but must be considered carefully, while a valid and applicable advance decision to refuse treatment is legally binding, so the difference matters.","source":"nice-ng108","quote":"Some approaches involve the production of legally binding advance decisions, which only cover decisions to refuse medical treatment, or the appointment of an attorney.","grade":"Not graded (NICE NG108 1.1.32 asks for information on the process; the distinction is in the introduction to the advance care planning recommendations)"},{"action":"Write the notes at the time, agree them with the person, and ask their consent to share them","why":"NICE says the notes must be made at the time of the discussion, should be agreed with the person at the time, and should be shared with other people only with the person's consent.","source":"nice-ng108","quote":"Practitioners must ensure that all notes made on advance care planning are contemporaneous.","grade":"Not graded (NICE NG108 1.1.40)"},{"action":"Give the person an accessible document recording their wishes, beliefs and preferences that they can take with them to show different services","why":"The person can show it to each service they meet. NICE says it may include who they want involved in decisions and their preferences on matters such as treatment, support or accommodation.","source":"nice-ng108","quote":"Provide the person with an accessible document that records their wishes, beliefs and preferences in relation to advance care planning and which they may take with them to show different services.","grade":"Not graded (NICE NG108 1.1.41)"},{"action":"Share the plan, with consent, with everyone involved in the person's care, and make sure a copy is where the person lives and goes with them into hospital, a care home or a hospice","why":"NICE's committee agreed that a copy in the person's home may be useful for practitioners to refer to in an emergency, when other information cannot be reached.","source":"nice-ng142","quote":"Service providers should have systems in place to ensure that adults approaching the end of their life each have a copy of their advance care plan available in their place of residence or with them if admitted to a hospital, care home or hospice.","grade":"Not graded (NICE NG142 1.6.3)"},{"action":"Review the plan at reviews of treatment or support while the person has capacity, amend it if they wish, and give the opportunity to review or make a plan when the person is reaching the end of life","why":"NICE quality standard QS13 notes that a person's wishes may change over time.","source":"nice-ng108","quote":"Review advance care plans at reviews of treatment or support, while the person has capacity, and amend as necessary, if the person wishes.","grade":"Not graded (NICE NG108 1.1.44)"},{"action":"If the person later lacks capacity for a decision, use the plan: a valid and applicable advance decision has effect as if the person were refusing the treatment now, an attorney acts within the authority the lasting power of attorney gives or is consulted, and any relevant written statement is considered in deciding the person's best interests","why":"In England and Wales the Act requires whoever decides a person's best interests to consider any relevant statement the person wrote while they had capacity.","source":"mca-2005","quote":"the person's past and present wishes and feelings (and, in particular, any relevant written statement made by him when he had capacity),","grade":"Statute (Mental Capacity Act 2005, sections 4(6)(a), 4(7)(c), 9(1) and 26(1); England and Wales)"}],"bestInClass":{"statement":"A voluntary offer made by the team rather than left to the patient, repeated over time; a conversation that takes account of the person's wishes, feelings, values and beliefs and helps them anticipate how their needs may change; a record written at the time, agreed with the person, held by the person and shared with consent with everyone involved in their care; and review at reviews of treatment. That is what NICE NG108 (2018) and NICE NG142 (2019) set out; NICE does not grade its recommendations. The two guidelines differ on when the offer is made. NG108 places it after diagnosis of a long-term or life-limiting condition, at the most suitable time and again later. NG142 and quality standard QS13 place it with adults approaching the end of life, which NICE describes as the final weeks and months and, for some conditions, longer. The sources also differ on who leads: NICE asks all health and social care practitioners who meet the person to help, while the EAPC international consensus (109 experts, 2017) recommends trained non-physician facilitators and adapting the content to the person's readiness and to worsening health. The trials do not show what the guidance hopes for. In ACTION (23 hospitals, six European countries, 1,117 patients with advanced lung or colorectal cancer) scripted conversations with certified facilitators did not change quality of life or symptoms at 12 weeks (T-score change -1.8 against -0.8, p = 0.59); more intervention patients used specialist palliative care (37 against 27 per cent) and had an advance directive on file (10 against 3 per cent); 67 per cent of patients considered the conversations helpful and 16 per cent found them distressing. A 2025 meta-analysis of 14 randomised studies in advanced cancer found more advance directives completed (odds ratio 7.93) and more palliative care use (odds ratio 1.39), with no difference in anxiety, depression, decisional conflict, satisfaction or quality of life, and inconsistent results on whether care matched preferences. NICE's own committee, in NG142, called the evidence for advance care planning unclear and found too little to recommend one service model, while agreeing that planning helps people to achieve the care and support they want. Whether planning changes the care a person finally receives is not settled. Two documents that belong beside these, NHS England's Universal Principles for Advance Care Planning (2022) and the GMC's guidance on care towards the end of life, could not be read and are not represented.","sources":["nice-ng108","nice-ng142","nice-qs13","eapc-consensus-2017","action-trial-2020","zhang-meta-2025"]},"variants":[{"name":"Offered from diagnosis, or offered when approaching the end of life","differs":"NICE NG108 offers the discussion once a person has a diagnosis likely to make planning useful and gives information about the process to anyone recently diagnosed with a long-term or life-limiting condition. NICE NG142 asks service providers for policies so that planning is offered to adults approaching the end of their life, and QS13 statement 2 reads \"Adults approaching the end of their life have opportunities to discuss advance care planning.\"","evidence":"Neither NICE guideline grades the recommendation. No trial read compares an offer at diagnosis with an offer later in the illness; the 2025 meta-analysis states that the optimal timing needs to be clarified.","sources":["nice-ng108","nice-ng142","nice-qs13","zhang-meta-2025"]},{"name":"Structured conversations led by a trained facilitator","differs":"A certified facilitator (in ACTION 39 were certified, predominantly nurses) holds one or two scripted conversations with the patient, with or without a personal representative present, using standard leaflets and a standard form for recording preferences (the Respecting Choices model tested in ACTION). The EAPC consensus recommends \"using trained non-physician facilitators to support the ACP process\".","evidence":"ACTION: no difference in quality of life, symptoms, coping, satisfaction or shared decision making at 12 weeks; more specialist palliative care use and more advance directives in hospital files; a mean of 1.3 conversations per patient; 67 per cent of patients considered the conversations helpful and 16 per cent found them distressing; recruitment was lower in intervention hospitals than in control hospitals, which the authors name as a key limitation. The EAPC recommendation is expert consensus (agreement between 68 and 100 per cent across its definitions and recommendations).","sources":["action-trial-2020","eapc-consensus-2017"]},{"name":"The legal documents in England and Wales","differs":"An advance decision to refuse treatment is made under the Mental Capacity Act 2005. A refusal of life-sustaining treatment must be in writing, signed and witnessed, and verified by a statement that it applies even if life is at risk (section 25). In deciding a person's best interests, any relevant written statement they made while they had capacity must be considered (section 4), which is the legal footing of an advance statement. NICE NG108 names the appointment of an attorney as the other formal route, and section 9 of the Act lets a person give an attorney authority to make decisions about their personal welfare when they no longer have capacity.","evidence":"Statute, which extends to England and Wales. The Act extends to England and Wales only (section 68), apart from two provisions on evidence of powers of attorney; the law in Scotland and Northern Ireland was not read; the GMC guidance for doctors across the UK could not be read.","sources":["mca-2005","nice-ng108"]},{"name":"Planning with someone who cannot take a full part","differs":"NICE NG142 asks service providers for processes \"to take into account the views of carers and other people important to the person if the person approaching the end of their life lacks capacity to make decisions in line with the Mental Capacity Act 2005\". NICE NG108 asks practitioners to help everyone take part, by finding the barriers to their involvement and providing communication support such as communication aids, advocacy, interpreters or speech and language therapy. Under the Act, the person deciding must, so far as reasonably practicable, permit and encourage the person to participate as fully as possible.","evidence":"Guidance and statute (England and Wales); not graded.","sources":["nice-ng142","nice-ng108","mca-2005"]}],"grades":[{"claim":"Offer advance care planning to adults approaching the end of life, with policies that take account of under-served and vulnerable groups","grade":"Not graded (NICE NG142 1.6.1)","source":"nice-ng142","quote":"Service providers should develop policies to ensure that advance care planning is offered to adults who are approaching the end of their life. Policies should take into account under-served and vulnerable groups."},{"claim":"Opportunities to discuss advance care planning for adults approaching the end of life (quality statement 2)","grade":"[new 2021]","source":"nice-qs13","quote":"Adults approaching the end of their life have opportunities to discuss advance care planning."},{"claim":"Offer a discussion at the most suitable time after diagnosis and at other times","grade":"Not graded (NICE NG108 1.1.34)","source":"nice-ng108"},{"claim":"Be sensitive, be prepared to postpone, and recognise that some people prefer not to have an advance care plan","grade":"Not graded (NICE NG108 1.1.36)","source":"nice-ng108","quote":"be sensitive, recognising that some people may prefer not to talk about this, or prefer not to have an advance care plan"},{"claim":"Share advance care plans in a clear and simple format with everyone involved in the person's care, with consent","grade":"Not graded (NICE NG108 1.1.42)","source":"nice-ng108","quote":"Practitioners should share any advance care plans in a clear and simple format with everyone involved in the person's care, if the person has given consent."},{"claim":"Protocols and plans should reflect that advance care planning is optional","grade":"Not graded (NICE NG108 1.1.30)","source":"nice-ng108","quote":"ensure that protocols and plans reflect the optional nature of advance care planning"},{"claim":"Advance statements have no legal force but must be considered carefully","grade":"Not graded (NICE NG108, introduction to the advance care planning recommendations)","source":"nice-ng108","quote":"do not have legal force, but practitioners must consider them carefully when future decisions are being made, and need to be able to justify not adhering to them."},{"claim":"Regular reviews of advance care plans are offered as part of care coordination","grade":"Not graded (NICE NG142 1.10.4)","source":"nice-ng142","quote":"ensure that regular discussions and reviews of care, holistic needs and advance care plans are offered"},{"claim":"Definition of advance care planning and 41 recommendations, including adapting to readiness and using trained non-physician facilitators","grade":"Delphi consensus, agreement 68-100% (109 experts)","source":"eapc-consensus-2017","quote":"Of the 109 experts (82 from Europe, 16 from North America, and 11 from Australia) who rated the ACP definitions and its 41 recommendations, agreement for each definition or recommendation was between 68-100%."},{"claim":"Advance care planning can identify substitute decision makers or prepare family members","grade":"Ungraded statement (ESMO 2021 text)","source":"esmo-eol-2021","quote":"Advance care planning with the patient can identify substitute decision makers, or prepare family members for death, a possible protective factor against later distress."},{"claim":"Structured advance care planning did not change quality of life at 12 weeks in advanced lung or colorectal cancer","grade":"Cluster-randomised trial, 1,117 patients","source":"action-trial-2020","quote":"Mean change in patients' quality of life did not differ between intervention and control groups (T-score -1.8 versus -0.8, p = 0.59), nor did changes in symptoms, coping, patient satisfaction, and shared decision-making."},{"claim":"Some patients found the conversations distressing","grade":"Cluster-randomised trial, 1,117 patients","source":"action-trial-2020","quote":"Sixteen percent of patients found ACP conversations distressing."},{"claim":"Advance care planning raised completion of advance directives and use of palliative care in advanced cancer, without improving anxiety, depression, satisfaction or quality of life","grade":"Meta-analysis of 14 randomised studies","source":"zhang-meta-2025","quote":"It was not effective in improving anxiety, depression, decisional conflicts, patient satisfaction, and quality of life."}],"sources":[{"key":"nhse-universal-principles-2022","label":"Universal Principles for Advance Care Planning (ACP)","publisher":"NHS England","year":2022,"url":"https://www.england.nhs.uk/publication/universal-principles-for-advance-care-planning/","read":"not-reachable","accessed":"2026-11-17"},{"key":"nice-ng108","label":"Decision-making and mental capacity (NG108), recommendations","publisher":"NICE","year":2018,"url":"https://www.nice.org.uk/guidance/ng108/chapter/Recommendations","gradingScheme":"NICE does not grade recommendations; the wording ('must', 'should', 'offer', 'consider') shows their strength.","read":"full-text","accessed":"2026-11-17"},{"key":"nice-ng142","label":"End of life care for adults: service delivery (NG142), recommendations","publisher":"NICE","year":2019,"url":"https://www.nice.org.uk/guidance/ng142/chapter/Recommendations","gradingScheme":"NICE does not grade recommendations; the wording shows their strength.","read":"full-text","accessed":"2026-11-17"},{"key":"nice-qs13","label":"End of life care for adults (QS13), quality statements (2011, last updated September 2021)","publisher":"NICE","year":2021,"url":"https://www.nice.org.uk/guidance/qs13/chapter/Quality-statements","gradingScheme":"Quality statements are not graded; each is tagged with the year it was written or updated ([new 2021], [2011, updated 2021]).","read":"public-summary","accessed":"2026-11-17"},{"key":"gmc-end-of-life-care","label":"Treatment and care towards the end of life: good practice in decision making","publisher":"General Medical Council","year":2024,"url":"https://www.gmc-uk.org/professional-standards/the-professional-standards/treatment-and-care-towards-the-end-of-life","read":"not-reachable","accessed":"2026-11-17"},{"key":"mca-2005","label":"Mental Capacity Act 2005, sections 1 (principles), 4 (best interests), 9 (lasting powers of attorney), 25 and 26 (advance decisions) and 68 (extent)","publisher":"UK Parliament (legislation.gov.uk); extends to England and Wales","year":2005,"url":"https://www.legislation.gov.uk/ukpga/2005/9/section/4","gradingScheme":"Statute, not a guideline: its provisions are law in England and Wales.","read":"full-text","accessed":"2026-11-17"},{"key":"esmo-eol-2021","label":"Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines","publisher":"ESMO (ESMO Open, Crawford et al.)","year":2021,"url":"https://doi.org/10.1016/j.esmoop.2021.100225","doi":"10.1016/j.esmoop.2021.100225","gradingScheme":"Recommendations carry a [level, grade] pair; the scheme is in the guideline's Supplementary Table S3, which was not read. The guideline says statements without grading were considered justified standard clinical practice by the experts and the ESMO Faculty; the sentence on advance care planning carries no grade.","read":"full-text","accessed":"2026-11-17"},{"key":"eapc-consensus-2017","label":"Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care","publisher":"The Lancet Oncology (Rietjens et al.)","year":2017,"url":"https://doi.org/10.1016/S1470-2045(17)30582-X","doi":"10.1016/S1470-2045(17)30582-X","gradingScheme":"Formal Delphi consensus; each definition and recommendation is reported with its percentage agreement.","read":"abstract","accessed":"2026-11-17"},{"key":"action-trial-2020","label":"Advance care planning in patients with advanced cancer: a 6-country, cluster-randomised clinical trial (ACTION)","publisher":"PLoS Medicine (Korfage et al.)","year":2020,"url":"https://doi.org/10.1371/journal.pmed.1003422","doi":"10.1371/journal.pmed.1003422","read":"full-text","accessed":"2026-11-17"},{"key":"zhang-meta-2025","label":"Effects of advance care planning for patients with advanced cancer: a meta-analysis of randomized controlled studies","publisher":"International Journal of Nursing Studies (Zhang et al.)","year":2025,"url":"https://doi.org/10.1016/j.ijnurstu.2025.105096","doi":"10.1016/j.ijnurstu.2025.105096","read":"abstract","accessed":"2026-11-17"},{"key":"esmo-acp-2014","label":"ESMO Clinical Practice Guidelines on palliative care: advanced care planning","publisher":"ESMO (Annals of Oncology, Schrijvers and Cherny)","year":2014,"url":"https://doi.org/10.1093/annonc/mdu241","doi":"10.1093/annonc/mdu241","read":"not-reachable","accessed":"2026-11-17"}],"upgrades":[],"gaps":["Whether advance care planning changes the care a person with cancer finally receives is not settled. ACTION found no effect on quality of life at 12 weeks, and the 2025 meta-analysis found inconsistent results on whether care matched preferences. ACTION was read in full on 17 November 2026; the meta-analysis was read as an abstract only.","The ESMO guideline on advance care planning (2014) could not be read: the publisher refused a script, no archived copy of the article was found and Europe PMC holds no abstract. On 17 November 2026 its DOI again led to a redirect page with no article text. Nothing here rests on it, and whether ESMO has replaced it was not established.","The EAPC consensus was read as an abstract only; its 41 recommendations, which are the most detailed international statement of the steps, are behind a paywall.","NHS England's Universal Principles for Advance Care Planning (2022), the national statement for England of what a good planning conversation looks like, could not be read: england.nhs.uk answered a script with an empty 202 response, and did so again on 17 November 2026, so its year of publication (2022) is as the first pass recorded it and was not re-checked. This page therefore states none of its principles, and the steps here come from NICE alone.","The GMC guidance Treatment and care towards the end of life could not be read: gmc-uk.org returned 403 to a script, and did so again on 17 November 2026, so the edition year shown for it could not be checked. This page therefore does not state what the regulator requires of doctors across the UK in these conversations, and has no UK-wide source for the steps.","No source read is specific to cancer except the trials. The NICE texts apply to any condition.","No source read sets a time by which the first conversation should have been offered after a diagnosis of advanced cancer, or an interval for review; NICE NG108 ties review to reviews of treatment or support, and NICE NG142 to key transition points such as discharge from hospital or a change in the goals of treatment.","On 17 November 2026 NICE listed no update to the advance care planning recommendations of NG108 (last reviewed 3 October 2018) or NG142 (one link added in October 2021), and no newer edition of the EAPC consensus or of the ESMO guidelines was found in Europe PMC or Crossref. The ESMO 2021 grading table (Supplementary Table S3) was not read.","The Scottish and Northern Irish statutes, the Scottish and Welsh national programmes and the Mental Capacity Act Code of Practice were not read, so this page states the legal position for England and Wales only.","The ASCO palliative care guideline update (2024) could not be read in full, so how it treats advance care planning is not stated here. Other systems' documents, such as POLST in the United States, are shown on the ReSPECT and DNACPR page."]},"route":"/protocols/advance-care-planning-for-adults-with-cancer/","neighbours":{"protocol":[{"id":"care-in-the-last-days-of-life","kind":"protocol","name":"Care in the last days of life: recognising dying, hydration, symptom control and anticipatory medicines","route":"/protocols/care-in-the-last-days-of-life/"},{"id":"consent-and-education-before-anticancer-treatment","kind":"protocol","name":"Consent and education before anticancer treatment","route":"/protocols/consent-and-education-before-anticancer-treatment/"},{"id":"distress-screening-and-referral","kind":"protocol","name":"Distress screening with the distress thermometer, and referral by need","route":"/protocols/distress-screening-and-referral/"},{"id":"early-palliative-care-referral","kind":"protocol","name":"Early palliative care alongside cancer treatment: referral criteria and timing","route":"/protocols/early-palliative-care-referral/"},{"id":"palliative-sedation-for-refractory-suffering","kind":"protocol","name":"Palliative sedation for refractory suffering at the end of life","route":"/protocols/palliative-sedation-for-refractory-suffering/"},{"id":"respect-and-dnacpr-decisions","kind":"protocol","name":"ReSPECT plans and DNACPR decisions in the UK: the conversation, the form, capacity and review","route":"/protocols/respect-and-dnacpr-decisions/"},{"id":"strong-opioids-for-cancer-pain","kind":"protocol","name":"Strong opioids for cancer pain: starting, titrating, rescue doses and preventing constipation","route":"/protocols/strong-opioids-for-cancer-pain/"}],"technology":[{"id":"palliative-care","kind":"technology","name":"Early integrated palliative care","route":"/technologies/palliative-care/"},{"id":"hospice-end-of-life","kind":"technology","name":"Hospice and end-of-life care","route":"/technologies/hospice-end-of-life/"}],"term":[{"id":"advance-care-planning","kind":"term","name":"Advance care planning","route":"/terms/advance-care-planning/"},{"id":"advance-decision-to-refuse-treatment","kind":"term","name":"Advance decision to refuse treatment (England and Wales)","route":"/terms/advance-decision-to-refuse-treatment/"},{"id":"gold-standards-framework","kind":"term","name":"Gold Standards Framework","route":"/terms/gold-standards-framework/"},{"id":"lasting-power-of-attorney-health-welfare","kind":"term","name":"Lasting power of attorney for health and welfare (England and Wales)","route":"/terms/lasting-power-of-attorney-health-welfare/"},{"id":"prognostic-evaluation-advanced-cancer","kind":"term","name":"Prognostic evaluation in advanced cancer","route":"/terms/prognostic-evaluation-advanced-cancer/"},{"id":"respect-process","kind":"term","name":"ReSPECT (Recommended Summary Plan for Emergency Care and Treatment)","route":"/terms/respect-process/"},{"id":"serious-illness-conversation-guide","kind":"term","name":"Serious Illness Conversation Guide","route":"/terms/serious-illness-conversation-guide/"}]}}